SCIENTIFIC PROGRAMME Saturday, 10 May 2025
PL-03 Plenary Session 08:30 – 10:00
P-15 Guided Poster Tour 12:45 – 14:45
Congress Hall Are ADHD medication safe? New data of long-term studies Chair: Jan K. Buitelaar, The Netherlands 001 In utero exposure to ADHD medication and long-term offspring neurodevelopmental outcomes Kathrine Bang Madsen, Demark
Congress Hall Foyer 2B (2 nd Floor)
Non-pharmacological treatment I Chair: Alexandra Philipsen, Germany 001
O ccupational priorities of adults with ADHD who participated in the cognitive-functional (Cog-Fun) intervention Jennifer Budman, Israel A. Maeir, S. Vittenberg-Zaguri E ffectiveness of the cognitive–functional inter- vention for adults with ADHD: Retrospective case series Jennifer Budman, Israel A. Maeir, S. Vittenberg-Zaguri Feasibility and initial effectiveness of the cognitive-functional (Cog-fun) intervention for adults with ADHD in jail Jennifer Budman, Israel A. Meir Abuhatzera, J. M. Cohen, K. Ben-Zvi Bonan, I. Velder Shukrun A DHD group coaching for adults: Findings from an 8-week in-person manualised program Marie Enback, Sweden ADHD group coaching: Comparing young adults in outpatient care and adults in non- clinical settings Marie Enback, Sweden V ideoconference-based cognitive behavioral therapy for Adults with ADHD: Secondary analysis of a randomized controlled trial Aiko Eto, Japan A. Endo, T. Yoshida, Y. Seki, K. Taguchi, M. Hongo, K. Takahashi, Y. Shiko, Y. Hirano, E. Shimizu E ffects of acute physical exercise on response inhibition in adults with ADHD and the role of exercise intensity Hannah Strenger, Germany A. Philipsen, A. Mehren Preliminary findings from an ongoing open longitudinal trial of therapist-guided internet- delivered treatment for adults with ADHD Aleksander Heltne, Norway T. Nordgreen, R. Kenter, R. Gulseth Evaluation of an ADHD study skills group for university students with ADHD Katherine Johnson, Australia A. Poulton, R. Maxwell P arent training adapted for adults with ADHD: A randomized controlled trial of the Improving Parenting Skills Adult ADHD (IPSA) program Therese Lindström, Sweden S. Buddgård, L. Westholm, M. Forster, S. Bölte, T. Hirvikoski
002
Long-term safety of methylphenidate in children and adolescents with ADHD: 2-years outcomes of the ADHD Drugs Use Chronic Effects (ADDUCE) study Tobias Banaschewski, Germany ADHD medications use and risks of mortality and unintentional injuries: A population-based cohort study Helen-Maria Vasiliadis, Canada
002
003
003
PC-01 Pro-Con-Debate 10:30 – 12:00
004
Congress Hall Does cognitive behavioral therapy adversely encour- age patients with ADHD to mask their true selves?
005
Moderator: Alexandra Philipsen, Germany Proponent: Saskia van der Oord, Belgium Opponent: Michael Meinzer, USA
006
P-14 Guided Poster Tour 12:45 – 14:45
Congress Hall Foyer 2B (2 nd Floor)
Experimental models Chair: Sarah Kittel-Schneider, Ireland 001
007
A proposal to Investigate age-related changes in ADHD: Insights from the THRSP-OE mouse model Raly James Custodio, Germany R. Custodio, E. Wascher, S. Getzmann, E. Yi, H. Kim, B. Kim, J. Cheong Photobiomodulation therapy may improve impulsivity on ADHD animal model Yujui Huang, Taiwan Experimental model for immune and meta- bolic comorbidities in neurodevelopmental disorders Pavla Nedbalová, Czech Republic M. Fencková A ttention-related impairment and contributing neuroinflammatory signaling in the prefrontal cortex of perinatal nicotine-exposed mice Sabide Duygu Uygun, Türkiye T. Kose, A. Bahadir-Varol, B. Uzay, E. Eren-Koçak
008
003
009
004
010
005
30
Made with FlippingBook Digital Publishing Software